ResearcherFujian Medical UniversityNo recent work listed

Hengce Zhang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5042433939. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Rucaparib, a PARP inhibitor, enhances β-lapachone-induced pyroptosis in pancreatic cancer cells Co-author DOI 10.21203/rs.3.rs-2018062/v1 ↗
X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in pancreatic cancer cells. First author DOI 10.1186/s12885-021-08979-y ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yingchun Liu · 2 shared papers, 2021–2022 · strength 0.34
- Paper Rucaparib, a PARP inhibitor, enhances β-lapachone-induced pyroptosis in pancreatic cancer cells DOI 10.21203/rs.3.rs-2018062/v1 ↗
- Paper X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in pancreatic cancer ce… DOI 10.1186/s12885-021-08979-y ↗
Yansong Zheng · 1 shared paper, 2021 · strength 0.16
- Paper X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone -induced apoptosis in pancreatic cancer ce… DOI 10.1186/s12885-021-08979-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.